Cardiac Implants Market Size & Share, by Product (Coronary Stents, Implantable Cardioverter-Defibrillators, Heart Rhythm Monitors, Hemodynamic Monitors, Pacemakers); Material (Alloys, Biological, Metals, Polymers); Procedure (Angioplasty, Open-Heart Surgery); Application (Acute Myocardial Infarction, Myocardial Ischemia, Arrhythmias, Congestive Heart Failures) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4111
Published Date: Feb 27, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Cardiac Implants Landscape

Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
BIOTRONIK SE & Co., KG
ZOLL Medical Corporation
Medtronic plc
LivaNova PLC
Abbott Laboratories
MEDICO S.R.L.
Lepu Medica

Browse Key Market Insights with Data Illustration:

Cardiac Implants Market Size & Share, Growth Forecasts 2035

In the News

Boston Scientific Corporation acquired clearance from the U.S. Food and Drug Administration (FDA) for its EMBOLD Fibered Detachable Coil that decreases the rate of peripheral vasculature blood flow.
BIOTRONIK, Inc. received approval of Renamic New, a software programmer for cardiac rhythm management devices, from the U.S. Food and Drug Administration (FDA).

Frequently Asked Questions (FAQ)

Higher prevalence of cardiovascular disorders and heart diseases, growing consumption of cigarettes, and increasing geriatric population are the major factors driving the growth of the cardiac implants market.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2035.

The possibility of infection owing to implantable pacemakers coupled with low awareness level about the advantages of cardiac implants and high cost associated with the usage of cardiac implants are estimated to be the growth hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Boston Scientific Corporation, BIOTRONIK SE & Co., KG, ZOLL Medical Corporation, Medtronic plc, LivaNova PLC, Abbott Laboratories, MEDICO S.R.L., Lepu Medical Technology Co., Ltd., Cook Group, Shree Pacetronix Ltd., and other key players.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, material, procedure, application, end-user, and by region.

The angioplasty segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Cardiac Implants Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the cardiac implants market?

What would be the CAGR of cardiac implants market over the forecast period?

What are the challenges affecting the cardiac implants market growth?

Which region will provide more business opportunities for growth of cardiac implants market in future?

Who are the major players dominating the cardiac implants market?

How are the company profiles selected?

What are the segments in the cardiac implants market?

Which sub-segment captures the largest market size in the procedure segment in the cardiac implants market?